Skip to content

Clinical trials

Phase 2 Seizures trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 2 Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20061
20183
20202
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
GlaxoSmithKline2
Neurocrine Biosciences2
Supernus Pharmaceuticals, Inc.2
Biohaven Therapeutics Ltd.1
Eisai Inc.1
Praxis Precision Medicines1
Takeda1
UCB Biopharma S.P.R.L.1
UCB Biopharma SRL1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures14
Epilepsy9
Epilepsies, Partial4
Drug Resistant Epilepsy3
Brain Diseases1
Central Nervous System Diseases1
Epilepsies, Myoclonic1
Hypoxia-Ischemia, Brain1
Lennox Gastaut Syndrome1
Malformations of Cortical Development1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.